Clinical Trials in Pittsburgh

Showing 13301-13320 of 18,076 trials

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

NCT02484703

This study will evaluate the safety, tolerability, efficacy, and pharmacokinetic and pharmacodynamic activity of 3 different dosages of RO5186582 compared with placebo. A total of approximately 46 participants will be enrolled, in order to have at least 32 evaluable, and will be randomly assigned to 1 of 4 treatments in a 1:1:1:1 ratio, with 9 children per treatment arm. The target ratio between 6-8 years and 9-11 years age groups is approximately 1:1 in each treatment arm, with a minimum of 3 children per age group in each treatment arm.

Down Syndrome

Hoffmann-La Roche45 participantsStarted Oct 2015

Phoenix, Arizona, United States • Decatur, Georgia, United States • Chicago, Illinois, United States +6 more locations

COMPLETEDNA< 1 mile

Evolution® Biliary Stent System-Fully Covered

NCT02104076

The Evolution® Biliary Stent System-Fully Covered study is a clinical trial approved by the US FDA to evaluate the effectiveness of the Evolution® Biliary Stent System-Fully Covered when used in palliation of malignant neoplasms in the biliary tree.

Carcinomas/Neoplasms

Cook Group Incorporated90 participantsStarted Sep 2014

Aurora, Colorado, United States • Jacksonville, Florida, United States • Tampa, Florida, United States +9 more locations

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

Evolution® Biliary Stent System-Fully Covered

Find Trials by Condition in Pittsburgh

Making Sense of a Positive Genetic Test Result for Huntington Disease

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma

Weaning And Variability Evaluation

Treatment Of Patients With Social Anxiety Disorder

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

Neuropsychological Evaluation of Psychiatric and Neurological Patients

Tissue Collection From People With Cystic Fibrosis

H7N9 Mix and Match With MF59 in Healthy Elderly Persons

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Large Diameter Advanta™ V12 Covered Stent Trial for Coarctation of the Aorta

Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression

A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects

Characterization of Childhood-Onset Obsessive-Compulsive Disorder

Study of Adult T-Cell Leukemia/Lymphoma Among Carriers of HTLV-1